IP Library Assignment 067822/0168
Patent Assignment
Reel/Frame 067822/0168

Assignment of Assignor's Interest

Recorded: 2024-06-24 Pages: 49
Assignor
AERIE PHARMACEUTICALS, INC.
Executed: 2024-06-18
Assignee
ALCON INC.
RUE LOUIS-D'AFFRY 6, FRIBOURG, 1701, SWITZERLAND
Covered Properties (89)
6-Aminoisoquinoline Compounds
Patent: 7,671,205 →
Application: 11/621,892 →
Publication: US US20070173530A1
6-Aminoisoquinoline Compounds
Patent: 8,455,647 →
Application: 13/230,105 →
Publication: US US20110319390A1
6-Aminoisoquinoline Compounds
Patent: 8,034,943 →
Application: 12/701,963 →
Publication: US US20100137364A1
Isoquinoline Compounds
Patent: 7,470,787 →
Application: 11/485,172 →
Publication: US US20070142429A1
Rho Kinase Inhibitors
Application: 14/754,787 →
Publication: US US20150297581A1
Rho Kinase Inhibitors
Application: 15/142,448 →
Publication: US US20160243102A1
Rho Kinase Inhibitors
Application: 15/858,995 →
Publication: US US20180344723A1
Rho Kinase Inhibitors
Application: 14/461,597 →
Publication: US US20140357652A1
Isoquinolinone Rho Kinase Inhibitors
Patent: 8,809,326 →
Application: 11/856,740 →
Publication: US US20080161297A1
6-Aminoisoquinoline Compounds
Patent: 8,357,699 →
Application: 13/017,708 →
Publication: US US20110183965A1
6-Aminoisoquinoline Compounds
Patent: 8,921,392 →
Application: 13/723,811 →
Publication: US US20130137721A1
6-Aminoisoquinoline Compounds
Patent: 9,365,518 →
Application: 14/583,439 →
Publication: US US20150119419A1
6-Aminoisoquinoline Compounds
Patent: 9,890,123 →
Application: 15/178,174 →
Publication: US US20160280656A1
6-Aminoisoquinoline Compounds
Application: 15/858,981 →
Publication: US US20180186746A1
6-Aminoisoquinoline Compounds
Application: 16/680,359 →
Publication: US US20200181090A1
6-Aminoisoquinoline Compounds
Patent: 8,455,513 →
Application: 11/621,887 →
Publication: US US20080167340A1
6-And 7-Amino Isoquinoline Compounds and Methods for Making and Using the Same
Patent: 8,871,757 →
Application: 12/704,822 →
Publication: US US20100144713A1
6-And 7-Amino Isoquinoline Compounds and Methods for Making and Using the Same
Patent: 8,455,514 →
Application: 12/009,326 →
Publication: US US20090186917A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Patent: 9,096,569 →
Application: 14/273,895 →
Publication: US US20140249201A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Patent: 9,512,101 →
Application: 14/790,376 →
Publication: US US20150299159A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Patent: 9,884,840 →
Application: 15/341,545 →
Publication: US US20170073325A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Application: 15/844,399 →
Publication: US US20180170898A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Application: 16/138,837 →
Publication: US US20190127346A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Application: 16/712,186 →
Publication: US US20200223818A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Application: 16/730,085 →
Publication: US US20200140407A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Application: 17/244,786 →
Publication: US US20210253547A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Patent: 8,759,388 →
Application: 13/442,263 →
Publication: US US20120196916A1
Beta- and Gamma-Amino-Isoquinoline Amide Compounds and Substituted Benzamide Compounds
Patent: 8,450,344 →
Application: 12/180,259 →
Publication: US US20100022585A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 14/138,592 →
Publication: US US20140187617A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 14/641,962 →
Publication: US US20150175549A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 15/076,216 →
Publication: US US20160272589A1
Dual Mechanism Inhibitors for the Treatment of Disease
Patent: 9,951,059 →
Application: 15/445,062 →
Publication: US US20170233381A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 15/924,089 →
Publication: US US20180215749A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 15/941,783 →
Publication: US US20180244666A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 16/435,254 →
Publication: US US20200002324A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 16/730,058 →
Publication: US US20200131171A1
Dual Mechanism Inhibitors for the Treatment of Disease
Application: 17/243,272 →
Publication: US US20210363141A1
Dual Mechanism Inhibitors for the Treatment of Disease
Patent: 8,716,310 →
Application: 13/768,594 →
Publication: US US20130158015A1
Dual Mechanism Inhibitors for the Treatment of Disease
Patent: 8,394,826 →
Application: 12/694,965 →
Publication: US US20100280011A1
Combination Therapy
Patent: 9,849,122 →
Application: 15/142,461 →
Publication: US US20160243105A1
Combination Therapy
Patent: 9,931,336 →
Application: 15/236,625 →
Publication: US US20160346269A1
Combination Therapy
Patent: 9,993,470 →
Application: 15/627,238 →
Publication: US US20170281613A1
Combination Therapy
Application: 15/901,361 →
Publication: US US20180333405A1
Combination Therapy
Application: 15/970,635 →
Publication: US US20180344724A1
Combination Therapy
Application: 16/730,015 →
Publication: US US20200129498A1
Combination Therapy
Application: 16/780,294 →
Publication: US US20200276179A1
Compositions for Treating Glaucoma or Reducing Intraocular Pressure
Application: 17/238,550 →
Publication: US US20210244722A1
Combination Therapy
Application: 17/238,554 →
Publication: US US20210236477A1
Combination Therapy
Application: 17/544,648 →
Publication: US US20220088000A1
Combination Therapy
Application: 14/213,940 →
Publication: US US20140275160A1
Combination Therapy
Patent: 9,415,043 →
Application: 14/213,961 →
Publication: US US20140275161A1
Process for the Preparation of Kinase Inhibitors and Intermediates Thereof
Application: 15/475,503 →
Publication: US US20170204065A1
Process for the Preparation of Kinase Inhibitors and Intermediates Thereof
Patent: 9,643,927 →
Application: 14/944,101 →
Publication: US US20170137384A1
Process for the Preparation of Kinase Inhibitors and Intermediates Thereof
Application: 15/776,762 →
Publication: US US20180370919A1
Implant Applicators and Methods of Administering Implants
Application: 15/695,810 →
Publication: US US20180368886A1
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application: 16/712,624 →
Publication: US US20200230157A1
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application: 15/746,797 →
Publication: US US20190083512A1
Beta-Amino-Isoquinolinyl Amide Compounds
Patent: 9,963,432 →
Application: 15/476,850 →
Publication: US US20180050990A1
Ophthalmic Compositions
Application: 17/841,433 →
Publication: US US20220304995A1
Ophthalmic Compositions
Application: 17/858,889 →
Publication: US US20220331308A1
Ophthalmic Compositions
Application: 17/894,809 →
Publication: US US20220409607A1
Ophthalmic Compositions
Application: 15/691,607 →
Publication: US US20180055833A1
Implant Applicators
Application: 16/330,025 →
Publication: US US20190374380A1
Methods for the Preparation of 6-Aminoisoquinoline
Patent: 9,840,468 →
Application: 15/395,068 →
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application: 16/936,257 →
Publication: US US20210002253A1
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application: 17/722,832 →
Publication: US US20230130470A1
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application: 15/941,993 →
Publication: US US20180327381A1
Mono-(Acid) Salts of 6-Aminoisoquinolines and Uses Thereof
Application: 17/501,799 →
Publication: US US20220144778A1
Mono-(Acid) Salts of 6-Aminoisoquinolines and Uses Thereof
Application: 16/370,240 →
Publication: US US20190322625A1
Isoquinoline-Steroid Conjugates and Uses Thereof
Application: 17/339,828 →
Publication: US US20210300874A1
Isoquinoline-Steroid Conjugates and Uses Thereof
Application: 16/557,779 →
Publication: US US20200071275A1
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application: 17/895,436 →
Publication: US US20230227430A1
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application: 16/570,849 →
Publication: US US20200102290A1
Compounds, Compositions and Methods for Treatment of Myopia
Application: 16/779,188 →
Publication: US US20200247760A1
Pharmaceutical Compositions for Treating Ocular Diseases or Disorders
Application: 16/810,149 →
Publication: US US20200306182A1
Heterobicyclic Carboxamides and Uses Thereof
Application: 17/642,092 →
Publication: US US20230002404A1
Treatments
Application: 17/917,853 →
Publication: US US20230149387A1
Stable Isoquinoline-Corticosteroid Conjugates and Uses Thereof
Application: 18/557,899 →
Publication: US US20240343755A1
Pharmaceutical Preparation
Application: 18/558,974 →
Publication: US US20240239750A1
Azetidinyl Pyrimidines and Uses Thereof
Application: 18/573,305 →
Publication: US US20240425496A1
Ophthalmic Pharmaceutical Compositions and Uses Thereof
Application: 18/510,437 →
Publication: US US20240091179A1
Ophthalmic Pharmaceutical Compositions and Uses Thereof
Application: 18/082,844 →
Publication: US US20230233493A1
Pyrazole Compounds and Uses Thereof
Application: 18/699,188 →
Publication: US US20250236611A1
Azetidinyl Pyrimidines and Uses Thereof
Application: 18/344,405 →
Publication: US US20240002392A1
Amino-Benzoisothiazole and Amino-Benzoisothiadiazole Amide Compounds
Application: 16/977,929 →
Publication: US US20210087184A1
Medical Implant
Application: 17/893,338 →
Publication: US US20240065970A1
Medical Implant
Application: 17/518,281 →
Publication: US US20220133532A1
Implant Delivery Device
Application: 17/714,333 →
Publication: US US20220331156A1
N-Substituted C6 Cyclyl Carboxamide Compounds and Uses Thereof
Application: 18/640,931 →
Publication: US US20240360075A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 11, 2008
From: DELONG, MITCHELL A.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD; ROYALTY, SUSAN M.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 020790/0664 →
Assignment of Assignor's Interest Nov 20, 2008
From: XSIRA PHARMACEUTICALS, INC.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 021868/0644 →
Assignment of Assignor's Interest Nov 20, 2008
From: SZNAIDMAN, MARCOS L.; OAKLEY, ROBERT H.; ECKHARDT, ALLEN E.; HUDSON, CHRISTINE
To: XSIRA PHARMACEUTICALS, INC.
Reel/Frame 021868/0424 →
Assignment of Assignor's Interest Nov 20, 2008
From: DELONG, MITCHELL A.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 021868/0398 →
Assignment of Assignor's Interest Nov 20, 2008
From: SCYNEXIS, INC.
To: XSIRA PHARMACEUTICALS, INC.
Reel/Frame 021868/0628 →
Assignment of Assignor's Interest Nov 20, 2008
From: PEEL, MICHAEL; RICHARDSON, THOMAS E.; MURRAY, CLARE LOUISE; NARASINGA RAO, BYAPPANAHALLY N.
To: SCYNEXIS, INC.
Reel/Frame 021868/0492 →
Security Agreement Mar 4, 2009
From: AERIE PHARMACEUTICALS, INC.
To: ACP IV, LP, (AS COLLATERAL AGENT)
Reel/Frame 022368/0097 →
Assignment of Assignor's Interest Mar 7, 2011
From: BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 025911/0697 →
Assignment of Assignor's Interest Mar 7, 2011
From: BOSANAC, TODD; GINN, JOHN DAVID; HICKEY, EUGENE RICHARD; KIRRANE, THOMAS MARTIN, JR.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 025911/0396 →
Assignment of Assignor's Interest May 11, 2011
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 026261/0212 →
Assignment of Assignor's Interest Jan 13, 2012
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 027528/0974 →
Assignment of Assignor's Interest Nov 7, 2012
From: DELONG, MITCHELL A.; ROYALTY, SUSAN M.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 029258/0825 →
Assignment of Assignor's Interest Feb 19, 2013
From: DELONG, MITCHELL A.; ROYALTY, SUSAN M.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 029832/0455 →
Assignment of Assignor's Interest Aug 6, 2014
From: DELONG, MITCHELL A.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD; ROYALTY, SUSAN M.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 033476/0551 →
Assignment of Assignor's Interest Aug 18, 2014
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 033552/0510 →
Assignment of Assignor's Interest Aug 18, 2014
From: BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 033552/0435 →
Assignment of Assignor's Interest Aug 18, 2014
From: BOSANAC, TODD; GINN, JOHN DAVID; HICKEY, EUGENE RICHARD; KIRRANE, THOMAS MARTIN, JR.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 033552/0389 →
Security Interest Sep 11, 2014
From: AERIE PHARMACEUTICALS, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS AGENT; DEERFIELD PARTNERS, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 033726/0043 →
Assignment of Assignor's Interest Dec 26, 2014
From: DELONG, MITCHELL A.; ROYALTY, SUSAN M.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 034587/0172 →
Assignment of Assignor's Interest Dec 11, 2015
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 037269/0503 →
Assignment of Assignor's Interest Dec 11, 2015
From: DELONG, MITCHELL A.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD; ROYALTY, SUSAN M.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 037269/0001 →
Assignment of Assignor's Interest Dec 11, 2015
From: BOSANAC, TODD; GINN, JOHN DAVID; HICKEY, EUGENE RICHARD; KIRRANE, THOMAS MARTIN, JR.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 037269/0331 →
Assignment of Assignor's Interest Dec 11, 2015
From: BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 037269/0422 →
Assignment of Assignor's Interest Jun 28, 2016
From: DELONG, MITCHELL A.; ROYALTY, SUSAN M.; STURDIVANT, JILL MARIE; HEINTZELMAN, GEOFFREY RICHARD
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 039028/0485 →
Assignment of Assignor's Interest Sep 12, 2016
From: BOSANAC, TODD; GINN, JOHN DAVID; HICKEY, EUGENE RICHARD; KIRRANE, THOMAS MARTIN, JR.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 039699/0124 →